Mahmoudreza Hadjighassem

Dr. Mahmoudreza Hadjighassem

Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MSMeysam Soleymani
Meysam Soleymani
SKSolmaz Khalighfard
Solmaz Khalighfard
SKSaeed Khodayari
Saeed Khodayari
HKHamid Khodayari
Hamid Khodayari
MKMohammad Reaz Kalhori
Mohammad Reaz Kalhori
AAAli Mohammad Alizadeh
Ali Mohammad Alizadeh
Folate-targeted iron oxide nanoparticles (FA@Fe3O4 NPs) were prepared by a one-pot hydrothermal method and then used as cancer theranostic agents by combining magnetic resonance imaging (MRI) and magnetic hyperthermia therapy (MHT). Crystal structure, morphology, magnetic properties, surface functional group, and heating efficacy of the synthesized nanoparticles were characterized by XRD, TEM, VSM, FTIR, and hyperthermia analyses. The results indicated that the crystal structure, magnetic properties, and heating efficacy of the magnetite nanoparticles were improved by hydrothermal treatment. Toxicity of the prepared NPs was assessed in vitro and in vivo on the mammary cells and BALB/c mice, respectively. The results of the in vitro toxicity analysis showed that the FA@Fe3O4 NPs are relatively safe even at high concentrations of the NPs up to 1000 µg mL−1. Also, the targetability of the FA@Fe3O4 NPs for the detection of folate over-expressed cancer cells was evaluated in an animal model of breast tumor using MRI analysis. It was observed that T2-weighted magnetic resonance signal intensity was decreased with the three-time injection of the FA@Fe3O4 NPs with 24 h interval at a safe dose (50 mg kg−1), indicating the accumulation and retention of the NPs within the tumor tissues. Moreover, the therapeutic efficacy of the MHT using the FA@Fe3O4 NPs was evaluated in vivo in breast tumor-bearing mice. Hyperthermia treatment was carried out under a safe alternating magnetic field permissible for magnetic hyperthermia treatment (f = 150 kHz, H = 12.5 mT). The therapeutic effects of the MHT were evaluated by monitoring the tumor volume during the treatment period. The results showed that the mice in the control group experienced an almost 3.5-fold increase in the tumor volume during 15 days, while, the mice in the MHT group had a mild increase in the tumor volume (1.8-fold) within the same period (P < 0.05). These outcomes give promise that FA@Fe3O4 NPs can be used as theranostic agents for the MRI and MHT applications.

27 April 2022 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
SMSeyed Mojtaba Mousavi
Seyed Mojtaba Mousavi
SMSeyed Mohammad Amin Mahdian
Seyed Mohammad Amin Mahdian
MEMohammad Saeid Ebrahimi
Mohammad Saeid Ebrahimi
MTMohammad Taghizadieh
Mohammad Taghizadieh
Massoud VosoughMassoud Vosough
Massoud Vosough
HMHamed Mirzaei
Hamed Mirzaei
Exosomes are small extracellular vesicles with sizes ranging from 30–150 nanometers that contain proteins, lipids, mRNAs, microRNAs, and double-stranded DNA derived from the cells of origin. Exosomes can be taken up by target cells, acting as a means of cell-to-cell communication. The discovery of these vesicles in body fluids and their participation in cell communication has led to major breakthroughs in diagnosis, prognosis, and treatment of several conditions (e.g., cancer). However, conventional isolation and evaluation of exosomes and their microRNA content suffers from high cost, lengthy processes, difficult standardization, low purity, and poor yield. The emergence of microfluidics devices with increased efficiency in sieving, trapping, and immunological separation of small volumes could provide improved detection and monitoring of exosomes involved in cancer. Microfluidics techniques hold promise for advances in development of diagnostic and prognostic devices. This review covers ongoing research on microfluidics devices for detection of microRNAs and exosomes as biomarkers and their translation to point-of-care and clinical applications.

12 October 2012 in Epilepsia
Verified
Journal Article
Closed access
PDF file
SESanaz Eftekhari
Sanaz Eftekhari
JHJafar Mehvari Habibabadi
Jafar Mehvari Habibabadi
MZMassoumeh Najafi Ziarani
Massoumeh Najafi Ziarani
SFSeyed Sohrab Hashemi Fesharaki
Seyed Sohrab Hashemi Fesharaki
MGMarzieh Gharakhani
Marzieh Gharakhani
MHMahmoudreza Hadjighassem
Mahmoudreza Hadjighassem

1 December 2015 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
MEMansoureh Eslami
Mansoureh Eslami
MSMohammad Sayyah
Mohammad Sayyah
MSMansoureh Soleimani
Mansoureh Soleimani
LALeila Alizadeh
Leila Alizadeh
MHMahmoudreza Hadjighassem
Mahmoudreza Hadjighassem

11 May 2015 in Synapse
Verified
Journal Article
Closed access
PDF file
FSFatemeh Saffarzadeh
Fatemeh Saffarzadeh
MEMohammad J. Eslamizade
Mohammad J. Eslamizade
TGTahereh Ghadiri
Tahereh Ghadiri
SMSayed Mostafa Modarres Mousavi
Sayed Mostafa Modarres Mousavi
MHMahmoudreza Hadjighassem
Mahmoudreza Hadjighassem
Ali GorjiAli Gorji
Ali Gorji

26 February 2015 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
MHMahmoudreza Hadjighassem
Mahmoudreza Hadjighassem
BKBehnam Kamalidehghan
Behnam Kamalidehghan
NSNima Shekarriz
Nima Shekarriz
ABArgavan Baseerat
Argavan Baseerat
NMNima Molavi
Nima Molavi
MGMeng-Yong Goh
Meng-Yong Goh
Dietary omega-6 and omega-3 fatty acids have remarkable impacts on the levels of DHA in the brain and retina. Low levels of DHA in plasma and blood hamper visual and neural development in children and cause dementia and cognitive decline in adults. The level of brain-derived neurotrophic factors (BDNF) changes with dietary omega-3 fatty acid intake. BDNF is known for its effects on promoting neurogenesis and neuronal survival. In this study, we examined the effect of the oral consumption of α-Linolenic acid (ALA) on blood levels of BDNF and Malondialdehyde (MDA) in healthy adult humans. 30 healthy volunteers, 15 men and 15 women, were selected randomly. Each individual served as his or her own control. Before consuming the Flaxseed oil capsules, 5cc blood from each individual was sampled in order to measure the plasma levels of BDNF and MDA as baseline controls. During the experiment, each individual was given 3 oral capsules of flaxseed oil, containing 500mg of alpha linolenic acid, daily for one week. Then, plasma levels of BDNF and MDA were tested. The plasma levels of BDNF and MDA significantly (P < 0.05) increased in individuals who received the oral capsules of ALA. Plasma levels of BDNF increased more in the women in comparison with the men. ALA treatment could be a feasible approach to reduce size of infarcts in stroke patients. Thus, ALA could be used in adjunction with routine stroke therapies to minimize brain lesions caused by stroke.